Inhibrx Biosciences (INBX) Shares Outstanding (2023 - 2026)

Inhibrx Biosciences (INBX) has reported Shares Outstanding (Entity) for 3 consecutive years, with $14.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 0.7% year-over-year to $14.6 million; the TTM figure through Dec 2025 stood at $14.6 million (up 0.7% YoY), while the FY2025 annual figure was $14.6 million, up 0.7% from the prior year.
• Shares Outstanding (Entity) advanced to $14.6 million in Q4 2025 per INBX's latest filing, from $14.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $14.6 million in Q4 2025 and bottomed at $10.9 million in Q2 2023.
• Historically, Shares Outstanding (Entity) has averaged $13.6 million across 3 years, with a median of $14.5 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 32.67% — and 2025, when it changed 0.0%.
• Inhibrx Biosciences' Shares Outstanding (Entity) stood at $11.8 million in 2023, then climbed by 22.85% to $14.5 million in 2024, then increased by 0.7% to $14.6 million in 2025.
• Business Quant data shows INBX's Shares Outstanding (Entity) at $14.6 million in Q4 2025, $14.5 million in Q3 2025, and $14.5 million in Q2 2025.